<DOC>
	<DOC>NCT02469454</DOC>
	<brief_summary>This study aims to assess whether there is change in the growth and development of newborns whose mothers will have a etonogestrel (ENG) releasing implant inserted in the first 24 to 48 hours of delivery compared with those with standard implant insertion (6 week postpartum).</brief_summary>
	<brief_title>Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development</brief_title>
	<detailed_description />
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Women who desire to use the ENG implant as a contraceptive method and desire to breastfeed her newborn for ate least 3 months; With no contraindication to breastfeeding, whose newborn is healthy, without malformations, born at term (gestational age â‰¥ 37 weeks), with appropriate weight for gestational age and with normal sucking ability Tobacco smokers, drug addicts or alcoholics; Women with educational levels lower than 5 years; Women with clinical conditions considered category 3 and 4 for implant use by the WHO; Women with histories of psychiatric illness; Women using medications that could alter the concentration of ENG, Women with known allergies to the local anesthetic lidocaine (used to place the implant); Women who wanted to keep their cyclic menstrual bleeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>etonogestrel-implant</keyword>
	<keyword>newborn</keyword>
	<keyword>growth</keyword>
	<keyword>Child Development</keyword>
</DOC>